Details of the Drug Combinations | DrugMAP

General Information of This Drug (ID: DM7LIV2)

Drug Name

REGN3051 DM7LIV2

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus infection	1D92	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

List of Combinatorial Drugs (CBD) Containing This Drug

1 Discontinued Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
REGN3048 + REGN3051	DCKGP57	REGN3048	Middle East Respiratory Syndrome (MERS)	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03301090) A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT03301090) A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051. U.S. National Institutes of Health.